Prudential Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Buy
+96,145
New +$1.09M ﹤0.01% 1531
2022
Q1
Sell
-35,230
Closed -$564K 2668
2021
Q4
$564K Sell
35,230
-205
-0.6% -$3.2K ﹤0.01% 2153
2021
Q3
$741K Buy
35,435
+380
+1% +$7.7K ﹤0.01% 1969
2021
Q2
$620K Buy
35,055
+270
+0.8% +$5.92K ﹤0.01% 2056
2021
Q1
$852K Buy
34,785
+100
+0.3% +$3.16K ﹤0.01% 1917
2020
Q4
$1.17M Buy
+34,685
New +$995K ﹤0.01% 1675

Other funds holding ORIC

Prudential Financial's ORIC Position: Q1 2026 in Review

Prudential Financial opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 96,145 shares worth $1.22M. The stake represents ﹤0.01% of the portfolio and ranks #1531 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ORIC as recently as Q4 2021.

Prudential Financial first reported a position in ORIC in Q4 2020 and has held it in 6 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Prudential Financial held 96,145 shares of Oric Pharmaceuticals worth $1.22M as of Q1 2026.
  • Oric Pharmaceuticals was a new Prudential Financial position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1531 holding.
  • Prudential Financial first reported a position in Oric Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.